30 likes | 158 Views
Chronic Opioid Therapy: To Drive or Not to Drive. 24 cancer patients on slow release morphine (average 209 mg /day) vs. 25 pain-free , drug-free cancer patients. “ No difference in psychomotor effects of a kind that would clearly be hazardous in traffic. ”
E N D
Chronic Opioid Therapy: To Drive or Not to Drive • 24 cancer patients on slow release morphine (average 209 mg/day) vs. 25 pain-free, drug-free cancer patients. “No difference in psychomotor effects of a kind that would clearly be hazardous in traffic.” • Vainio et al., Lancet, 1995 • Chronic pain patients on opioids perform similarly to controls who had passed driving tests • Galski et al., J Pain Symptom Manage, 2000
Chronic Opioid Therapy: To Drive or Not to Drive • 30 chronic pain patients on opioids vs. 49 matched controls without pain filmed on a prescribed 15 mile community ride. Also tested subjects for psychomotor speed and eye-hand coordination. “No consistent, significant differences between non-pain and chronic pain populations on following dependent variables - driving errors, speed of completing obstacle course, cones or barrels impacted or knocked down.” • Chapman et al., APS Bulletin, 2001
Chronic Opioid Therapy: To Drive or Not to Drive • Studies have shown that patients with unrelieved chronic pain perform worse on cognitive and motor tasks than individuals on opioid therapy • Sjogrenet al., Pain, 2000; Tassain et al., Pain, 2003